Jove
Visualize
Contact Us

Related Concept Videos

Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K
Epigenetic Regulation01:37

Epigenetic Regulation

3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.0K
Replicative Cell Senescence02:15

Replicative Cell Senescence

3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Overview of Transposition and Recombination02:13

Overview of Transposition and Recombination

15.4K
Transposons make up a significant part of genomes of various organisms. Therefore, it is believed that transposition played a major evolutionary role in speciation by changing genome sizes and modifying gene expression patterns. For example, in bacteria, transposition can lead to conferring antibiotic resistance. Movement of transposable elements within the genetic pool of pathogenic bacteria can aid in transfer of antibiotic-resistant genetic elements. In eukaryotes, transposons can carry out...
15.4K
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. Dysregulation Of Transposon Transcription Profiles In Cancer Cells Resembles That Of Embryonic Stem Cells.
  1. Home
  2. Dysregulation Of Transposon Transcription Profiles In Cancer Cells Resembles That Of Embryonic Stem Cells.

Related Experiment Video

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

747

Dysregulation of Transposon Transcription Profiles in Cancer Cells Resembles That of Embryonic Stem Cells.

Anna I Solovyeva1,2, Roman V Afanasev1, Marina A Popova1,3

  • 1Lab of the Non-Coding DNA Studies, Institute of Cytology, Russian Academy of Sciences, 194064 St. Petersburg, Russia.

Current Issues in Molecular Biology
|August 28, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

Transposable elements (TEs) show similar expression in embryonic stem cells (ESCs) and cancer. Key TEs like HERVH, LTR7, HERV-Fc1, and HERV-Fc2 are downregulated in cancer, suggesting roles in pluripotency and potential therapeutic targets.

Keywords:
HERV-Fc1HERV-Fc2HERVHcancer cell linescancer-associated fibroblastsembryonic stem cellspluripotencyrepeatomeretrovirusestransposonstumortumor microenvironment

More Related Videos

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
11:37

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

Published on: February 18, 2015

13.8K
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

12.9K

Related Experiment Videos

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

747
In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
11:37

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

Published on: February 18, 2015

13.8K
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

12.9K

Area of Science:

  • Genomics
  • Epigenetics
  • Cancer Biology

Background:

  • Transposable elements (TEs) constitute a significant fraction of mammalian genomes.
  • TEs are implicated in embryonic development and cancer initiation/progression.
  • Understanding TE expression dynamics is crucial for developmental and cancer research.

Purpose of the Study:

  • To characterize and compare transposable element (TE) expression profiles in embryonic stem cells (ESCs), cancer cell lines, tumor tissues, and the tumor microenvironment (TME).
  • To identify specific TEs involved in pluripotency regulation and cancer development.
  • To explore TE expression differences between tumor bulk and TME.

Main Methods:

  • Comparative transcriptomic analysis of TE expression.
  • Analysis of TE profiles across ESCs, cancer cell lines, tumor tissues, and TME samples.
  • Identification of differentially expressed TEs, including HERVH, LTR7, HERV-Fc1, HERV-Fc2, MSR1, CER, and ALR.
  • Main Results:

    • TE expression profiles in cancer cells share similarities with ESCs.
    • Four TEs (HERVH, LTR7, HERV-Fc1, HERV-Fc2) were significantly downregulated in cancer compared to ESCs, with HERV-Fc1 and HERV-Fc2 showing novel upregulation in ESCs.
    • Tandemly repeated sequences (MSR1, CER, ALR) were upregulated in cancer; distinct TE profiles were observed in the TME, with some TEs specific to the TME and absent in normal tissues.

    Conclusions:

    • TEs play regulatory roles in both embryonic development and cancer.
    • Specific TEs, particularly HERV-Fc1 and HERV-Fc2, may be key regulators of pluripotency.
    • Dysregulated TE expression in the TME suggests novel therapeutic targets for anti-cancer strategies.